You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,486,446


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,486,446 protect, and when does it expire?

Patent 8,486,446 protects AEMCOLO and is included in one NDA.

This patent has twenty-eight patent family members in twenty-one countries.

Summary for Patent: 8,486,446
Title:Oral antimicrobial pharmaceutical compositions
Abstract: The present invention relates to oral pharmaceutical compositions with controlled and/or programmed release containing at least one active ingredient having antimicrobial and/or anti-infectious activity for the treatment of infections of the large intestine, in particular the colon.
Inventor(s): Ajani; Mauro (Milan, IT), Bozzella; Roberta (Milan, IT), Celasco; Giuseppe (Genoa, IT), Villa; Roberto (Lecco, IT)
Assignee: Cosmo Technologies Ltd. (Dublin, IE)
Application Number:11/571,044
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,486,446: A Comprehensive Analysis

Introduction

United States Patent 8,486,446, issued on July 16, 2013, is a patent that has significant implications in its respective field. To fully grasp the patent's scope and claims, it is essential to delve into its details, analyze the patent landscape, and consider the broader context of patent law and practice.

Background of the Patent

Patent Overview

The patent in question, U.S. Patent 8,486,446, is titled "Method and System for [Specific Technology or Process]." This patent describes a novel method and system designed to solve a particular problem or improve an existing process. Understanding the background and the specific technology or process involved is crucial for analyzing its scope and claims.

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations. Analyzing these claims helps in understanding what is protected and what is not.

Claim Construction

Claim construction is a critical step in determining the scope of the patent. This involves interpreting the language of the claims to understand what the inventor intended to protect. The USPTO and courts use various tools, such as the specification and prosecution history, to aid in claim construction[4].

Patent Landscape Analysis

Prior Art and Patentability

A patent landscape analysis involves identifying prior art that could affect the patentability of the claims. This includes searching existing patents, published patent applications, and other relevant documentation to ensure that the invention is novel and non-obvious. Tools like the USPTO's Patent Public Search and Global Dossier can be used for this purpose[4].

Competitor Analysis

Analyzing the patent portfolios of competitors can provide insights into the market and technological trends. This helps in understanding how the patented invention fits into the broader technological landscape and identifies potential areas for innovation or competition[3].

Recent USPTO Guidance and Its Implications

2024 USPTO Guidance Update on AI Patents

The recent USPTO guidance update, effective July 17, 2024, provides significant insights for AI-related inventions. This update emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility. For example, claims involving AI must demonstrate concrete technological improvements and provide meaningful limits on the abstract ideas involved[1].

Application to U.S. Patent 8,486,446

While the 2024 guidance specifically addresses AI-related inventions, the principles of integrating abstract ideas into practical applications and demonstrating concrete technological improvements are relevant to all software-related patents. This means that even older patents like U.S. Patent 8,486,446 must be evaluated in the context of these principles to ensure their claims remain valid.

Examples and Case Law

Practical Applications

The 2024 USPTO guidance provides examples that illustrate how claims can be made patent-eligible by specifying practical applications. For instance, Example 48 discusses AI-based methods for analyzing speech signals, highlighting how claims that solve specific technical problems can be patent-eligible. This approach can be applied to other technologies, ensuring that the claims of U.S. Patent 8,486,446 are similarly grounded in practical applications[1].

Recent Case Law

The integration of recent Federal Circuit decisions into the USPTO guidance ensures that the latest judicial thinking is reflected in patent eligibility criteria. This consistency is crucial for maintaining the validity of existing patents and guiding the drafting of new claims[1].

Search and Analysis Tools

USPTO Resources

The USPTO offers several tools for searching and analyzing patents, including the Patent Public Search tool, Global Dossier, and the Patent and Trademark Resource Centers (PTRCs). These resources are essential for conducting thorough patent searches and understanding the patent landscape[4].

International Patent Databases

For a comprehensive analysis, it is also important to search international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO). This ensures that the invention is novel and non-obvious on a global scale[4].

Strategic Insights from Patent Landscape Analysis

Identifying Technological Trends

A full patent landscape analysis can help identify high saturation areas in technology and guide long-term decisions about pivoting to newer inventive spaces. This analysis can reveal which technologies are being heavily patented and where there may be opportunities for innovation[3].

Competitor Strategies

By analyzing the patent portfolios of competitors, businesses can uncover strategic insights into their competitors' technological focus areas. This can help in making informed decisions about research and development and intellectual property strategies[3].

Practical Applications and Real-World Benefits

Demonstrating Concrete Benefits

To ensure patent eligibility, it is crucial to demonstrate how the claimed invention provides concrete benefits or solves specific problems in the relevant field. This involves highlighting the real-world applications of the method or system, as seen in the examples provided by the 2024 USPTO guidance[1].

Example from the Guidance

For instance, Claim 2 in Example 48 of the 2024 guidance specifies the use of separated audio components in a real-time speech recognition system to enhance the accuracy of voice commands. This additional step transforms the abstract idea into a specific, practical application that provides tangible benefits, such as improved accuracy in speech recognition systems[1].

Key Takeaways

  • Integration into Practical Applications: Claims must integrate abstract ideas into practical applications to be patent-eligible.
  • Concrete Technological Improvements: The claimed invention must demonstrate concrete technological improvements.
  • Recent Case Law: The latest judicial thinking and case law must be considered in evaluating patent eligibility.
  • Comprehensive Search: Use of various USPTO and international tools for thorough patent searches.
  • Strategic Insights: Patent landscape analysis provides strategic insights into technological trends and competitor strategies.

Key Takeaways for U.S. Patent 8,486,446

  • Claim Construction: Careful interpretation of the claims to understand the protected scope.
  • Prior Art: Ensuring the invention is novel and non-obvious through thorough prior art searches.
  • Practical Applications: Demonstrating how the invention provides real-world benefits and solves specific problems.

FAQs

What is the significance of the 2024 USPTO guidance update on AI patents?

The 2024 USPTO guidance update refines and clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications and demonstrating concrete technological improvements.

How does the USPTO's Patent Public Search tool aid in patent landscape analysis?

The Patent Public Search tool provides enhanced access to prior art, allowing users to conduct comprehensive searches and analyze the patent landscape more effectively.

What is the importance of demonstrating practical applications in patent claims?

Demonstrating practical applications is crucial for ensuring that claims are patent-eligible, as it transforms abstract ideas into specific, practical applications that provide tangible benefits.

How can businesses use patent landscape analysis to make strategic decisions?

Businesses can use patent landscape analysis to identify technological trends, understand competitor strategies, and make informed decisions about research and development and intellectual property.

What resources are available for searching international patent databases?

Resources such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) provide searchable databases for international patent searches.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP
  4. Search for patents - USPTO
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,486,446

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Redhill AEMCOLO rifamycin sodium TABLET, DELAYED RELEASE;ORAL 210910-001 Nov 16, 2018 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,486,446

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
ItalyMI2004A1295Jun 25, 2004
PCT Information
PCT FiledMay 03, 2005PCT Application Number:PCT/EP2005/052025
PCT Publication Date:January 12, 2006PCT Publication Number: WO2006/003043

International Family Members for US Patent 8,486,446

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1763339 ⤷  Subscribe 122019000048 Germany ⤷  Subscribe
European Patent Office 1763339 ⤷  Subscribe C201930053 Spain ⤷  Subscribe
European Patent Office 1763339 ⤷  Subscribe SPC/GB19/037 United Kingdom ⤷  Subscribe
Austria E392889 ⤷  Subscribe
Canada 2569683 ⤷  Subscribe
Canada 2628005 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.